Yale School of Medicine's Chair of Psychiatry, John Krystal, MD, investigated a new #schizophrenia drug. In The Lancet last week, researchers say #Emraclidine showed significant #antipsychotic effect, and could be an important treatment option.
https://medicine.yale.edu/news-article/krystal-research-published-in-the-lancet/